How should I interpret a lipid panel with total cholesterol 149 mg/dL, triglycerides 207 mg/dL, LDL cholesterol 55 mg/dL, and HDL cholesterol 53 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Lipid Panel Interpretation

This lipid panel shows borderline-elevated triglycerides (207 mg/dL) requiring lifestyle intervention, while your LDL and total cholesterol are at optimal levels.

Individual Parameter Analysis

Total Cholesterol: 149 mg/dL

  • Optimal range - Well below the desirable threshold of <200 mg/dL 1
  • No intervention needed for this parameter alone

LDL Cholesterol: 55 mg/dL

  • Excellent level - Significantly below the optimal target of <100 mg/dL 1, 2
  • This is even below the more aggressive target of <70 mg/dL recommended for high-risk patients 3
  • No LDL-lowering therapy indicated

HDL Cholesterol: 53 mg/dL

  • Acceptable but not optimal - Above the minimum threshold of 40 mg/dL for men (or 50 mg/dL for women) 3, 2
  • While not flagged as low-risk, this level provides some cardiovascular protection
  • Higher levels (>60 mg/dL) would be more protective

Triglycerides: 207 mg/dL

  • Borderline-elevated - Falls in the 200-499 mg/dL range requiring attention 3
  • This is above the desirable threshold of <150 mg/dL 2 but below levels requiring immediate pharmacologic intervention

Critical Calculation: Non-HDL Cholesterol

Non-HDL-C = Total Cholesterol - HDL-C = 149 - 53 = 96 mg/dL

  • Excellent level - Well below the target of <130 mg/dL recommended when triglycerides are 200-499 mg/dL 3
  • This represents your total atherogenic cholesterol burden and is at goal

Management Recommendations

Immediate Actions for Triglycerides (207 mg/dL):

  1. Dietary modifications 3:

    • Reduce saturated fats to <7% of total calories
    • Limit cholesterol intake to <200 mg/day
    • Reduce simple sugars and refined carbohydrates
    • Increase omega-3 fatty acids from fish
    • Eliminate or significantly reduce alcohol consumption - critical for triglyceride management 3

  2. Lifestyle interventions 3, 1:

    • Daily physical activity (at least 30 minutes of moderate-intensity exercise most days)
    • Weight management if overweight (body mass index >25 kg/m²)

  3. Rule out secondary causes:

    • Assess glycemic control (check for diabetes or prediabetes)
    • Review medications that may elevate triglycerides
    • Evaluate thyroid function if not recently checked

Monitoring Strategy

  • Repeat fasting lipid panel in 3-6 months after implementing lifestyle changes 3
  • If triglycerides remain >200 mg/dL despite lifestyle modifications, consider fibrate therapy (gemfibrozil or fenofibrate) 3, 2

Important Caveats

Common pitfall: Do not use bile acid sequestrants when triglycerides are >200 mg/dL, as they are relatively contraindicated and can worsen hypertriglyceridemia 3.

Key point: Your LDL is already at an excellent level (55 mg/dL), so statin therapy is not indicated unless you have established cardiovascular disease or diabetes requiring treatment for other reasons. The focus should be exclusively on triglyceride reduction through lifestyle measures first 3, 2.

Risk context: While your triglycerides are elevated, your overall atherogenic burden (non-HDL-C of 96 mg/dL) is excellent, suggesting lower cardiovascular risk than triglycerides alone would indicate 3, 4.

References

Related Questions

Interpret a lipid panel showing total cholesterol 168 mg/dL, triglycerides 97 mg/dL, HDL‑C 96 mg/dL, and LDL‑C 51 mg/dL and advise on management.
How should a patient with hypercholesterolemia and a lipid panel showing total cholesterol 280 mg/dL, LDL (low-density lipoprotein) 143 mg/dL, HDL (high-density lipoprotein) 117 mg/dL, and triglycerides 100 mg/dL be managed?
For a patient with total cholesterol 240 mg/dL, LDL cholesterol 173 mg/dL, triglycerides 72 mg/dL, HDL cholesterol 54 mg/dL, and VLDL cholesterol 13 mg/dL, what is the recommended treatment plan?
In a 38‑year‑old man with total cholesterol 183 mg/dL, HDL‑cholesterol 52 mg/dL, triglycerides 131 mg/dL, calculated LDL‑cholesterol 106 mg/dL, non‑HDL‑cholesterol 131 mg/dL, LDL particle number 1001 nmol/L, elevated small dense LDL particles, apolipoprotein B 91 mg/dL, lipoprotein(a) 42 nmol/L, and high‑sensitivity C‑reactive protein 3.6 mg/L, what is the recommended initial lipid‑lowering therapy and lifestyle modifications?
Given a total cholesterol of 3.3–3.6 mmol/L, should I obtain a full lipid panel (LDL‑C, HDL‑C, triglycerides) and is carotid duplex ultrasound indicated, or is a CT scan of the neck necessary?
Can melanoma present with a green or blue coloration?
What is the appropriate postoperative management after coronary artery bypass graft (CABG) surgery?
What are the recommended fluid resuscitation strategies in the emergency setting for adults with different types of shock?
How should haloperidol (Haldol) and lorazepam (Ativan) be co‑administered, including dosing, monitoring, and precautions?
Serum creatinine increased from 1.31 mg/dL to 1.38 mg/dL in one day; does this indicate acute kidney injury?
What is the appropriate management for a patient presenting with ventricular bigeminy and dizziness?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.